Global Quetiapine Fumarate Sustained Release Tablets Supply, Demand and Key Producers, 2024-2030

Page: 98

Published Date: 01 Aug 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Quetiapine Fumarate Sustained Release Tablets market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Quetiapine Fumarate Sustained Release Tablets demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Quetiapine Fumarate Sustained Release Tablets, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Quetiapine Fumarate Sustained Release Tablets that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Quetiapine Fumarate Sustained Release Tablets total market, 2019-2030, (USD Million)
Global Quetiapine Fumarate Sustained Release Tablets total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Quetiapine Fumarate Sustained Release Tablets total market, key domestic companies, and share, (USD Million)
Global Quetiapine Fumarate Sustained Release Tablets revenue by player, revenue and market share 2019-2024, (USD Million)
Global Quetiapine Fumarate Sustained Release Tablets total market by Type, CAGR, 2019-2030, (USD Million)
Global Quetiapine Fumarate Sustained Release Tablets total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Quetiapine Fumarate Sustained Release Tablets market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Mylan N.V., Torrent Pharmaceuticals, Lupin Limited, Sandoz, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Quetiapine Fumarate Sustained Release Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Quetiapine Fumarate Sustained Release Tablets Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Quetiapine Fumarate Sustained Release Tablets Market, Segmentation by Type
    50mg
    200mg
    300mg
    400mg

Global Quetiapine Fumarate Sustained Release Tablets Market, Segmentation by Application:
    Hospital
    Clinic
    Others

Companies Profiled:
    Luye Pharma Limited
    PHARMATHEN INVESTMENTS GROUP LIMITED
    Seroquel
    Teva Pharmaceutical Industries
    Dr. Reddy's Laboratories
    Sun Pharmaceutical Industries
    Mylan N.V.
    Torrent Pharmaceuticals
    Lupin Limited
    Sandoz

Key Questions Answered
1. How big is the global Quetiapine Fumarate Sustained Release Tablets market?
2. What is the demand of the global Quetiapine Fumarate Sustained Release Tablets market?
3. What is the year over year growth of the global Quetiapine Fumarate Sustained Release Tablets market?
4. What is the total value of the global Quetiapine Fumarate Sustained Release Tablets market?
5. Who are the Major Players in the global Quetiapine Fumarate Sustained Release Tablets market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Quetiapine Fumarate Sustained Release Tablets Introduction
    1.2 World Quetiapine Fumarate Sustained Release Tablets Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Quetiapine Fumarate Sustained Release Tablets Total Market by Region (by Headquarter Location)
        1.3.1 World Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030)
        1.3.3 China Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030)
        1.3.4 Europe Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030)
        1.3.5 Japan Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030)
        1.3.6 South Korea Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030)
        1.3.7 ASEAN Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030)
        1.3.8 India Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Quetiapine Fumarate Sustained Release Tablets Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030)
    2.2 World Quetiapine Fumarate Sustained Release Tablets Consumption Value by Region
        2.2.1 World Quetiapine Fumarate Sustained Release Tablets Consumption Value by Region (2019-2024)
        2.2.2 World Quetiapine Fumarate Sustained Release Tablets Consumption Value Forecast by Region (2025-2030)
    2.3 United States Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030)
    2.4 China Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030)
    2.5 Europe Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030)
    2.6 Japan Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030)
    2.7 South Korea Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030)
    2.8 ASEAN Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030)
    2.9 India Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030)

3 World Quetiapine Fumarate Sustained Release Tablets Companies Competitive Analysis
    3.1 World Quetiapine Fumarate Sustained Release Tablets Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Quetiapine Fumarate Sustained Release Tablets Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Quetiapine Fumarate Sustained Release Tablets in 2023
        3.2.3 Global Concentration Ratios (CR8) for Quetiapine Fumarate Sustained Release Tablets in 2023
    3.3 Quetiapine Fumarate Sustained Release Tablets Company Evaluation Quadrant
    3.4 Quetiapine Fumarate Sustained Release Tablets Market: Overall Company Footprint Analysis
        3.4.1 Quetiapine Fumarate Sustained Release Tablets Market: Region Footprint
        3.4.2 Quetiapine Fumarate Sustained Release Tablets Market: Company Product Type Footprint
        3.4.3 Quetiapine Fumarate Sustained Release Tablets Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Quetiapine Fumarate Sustained Release Tablets Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Quetiapine Fumarate Sustained Release Tablets Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Quetiapine Fumarate Sustained Release Tablets Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Quetiapine Fumarate Sustained Release Tablets Consumption Value Comparison
        4.2.1 United States VS China: Quetiapine Fumarate Sustained Release Tablets Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Quetiapine Fumarate Sustained Release Tablets Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Quetiapine Fumarate Sustained Release Tablets Companies and Market Share, 2019-2024
        4.3.1 United States Based Quetiapine Fumarate Sustained Release Tablets Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue, (2019-2024)
    4.4 China Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue and Market Share, 2019-2024
        4.4.1 China Based Quetiapine Fumarate Sustained Release Tablets Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue, (2019-2024)
    4.5 Rest of World Based Quetiapine Fumarate Sustained Release Tablets Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Quetiapine Fumarate Sustained Release Tablets Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Quetiapine Fumarate Sustained Release Tablets Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 50mg
        5.2.2 200mg
        5.2.3 300mg
        5.2.4 400mg
    5.3 Market Segment by Type
        5.3.1 World Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2019-2024)
        5.3.2 World Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2025-2030)
        5.3.3 World Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Quetiapine Fumarate Sustained Release Tablets Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2019-2024)
        6.3.2 World Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2025-2030)
        6.3.3 World Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Luye Pharma Limited
        7.1.1 Luye Pharma Limited Details
        7.1.2 Luye Pharma Limited Major Business
        7.1.3 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.1.4 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Luye Pharma Limited Recent Developments/Updates
        7.1.6 Luye Pharma Limited Competitive Strengths & Weaknesses
    7.2 PHARMATHEN INVESTMENTS GROUP LIMITED
        7.2.1 PHARMATHEN INVESTMENTS GROUP LIMITED Details
        7.2.2 PHARMATHEN INVESTMENTS GROUP LIMITED Major Business
        7.2.3 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.2.4 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 PHARMATHEN INVESTMENTS GROUP LIMITED Recent Developments/Updates
        7.2.6 PHARMATHEN INVESTMENTS GROUP LIMITED Competitive Strengths & Weaknesses
    7.3 Seroquel
        7.3.1 Seroquel Details
        7.3.2 Seroquel Major Business
        7.3.3 Seroquel Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.3.4 Seroquel Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Seroquel Recent Developments/Updates
        7.3.6 Seroquel Competitive Strengths & Weaknesses
    7.4 Teva Pharmaceutical Industries
        7.4.1 Teva Pharmaceutical Industries Details
        7.4.2 Teva Pharmaceutical Industries Major Business
        7.4.3 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.4.4 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
        7.4.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
    7.5 Dr. Reddy's Laboratories
        7.5.1 Dr. Reddy's Laboratories Details
        7.5.2 Dr. Reddy's Laboratories Major Business
        7.5.3 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.5.4 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
        7.5.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
    7.6 Sun Pharmaceutical Industries
        7.6.1 Sun Pharmaceutical Industries Details
        7.6.2 Sun Pharmaceutical Industries Major Business
        7.6.3 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.6.4 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
        7.6.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
    7.7 Mylan N.V.
        7.7.1 Mylan N.V. Details
        7.7.2 Mylan N.V. Major Business
        7.7.3 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.7.4 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Mylan N.V. Recent Developments/Updates
        7.7.6 Mylan N.V. Competitive Strengths & Weaknesses
    7.8 Torrent Pharmaceuticals
        7.8.1 Torrent Pharmaceuticals Details
        7.8.2 Torrent Pharmaceuticals Major Business
        7.8.3 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.8.4 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Torrent Pharmaceuticals Recent Developments/Updates
        7.8.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Lupin Limited
        7.9.1 Lupin Limited Details
        7.9.2 Lupin Limited Major Business
        7.9.3 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.9.4 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Lupin Limited Recent Developments/Updates
        7.9.6 Lupin Limited Competitive Strengths & Weaknesses
    7.10 Sandoz
        7.10.1 Sandoz Details
        7.10.2 Sandoz Major Business
        7.10.3 Sandoz Quetiapine Fumarate Sustained Release Tablets Product and Services
        7.10.4 Sandoz Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Sandoz Recent Developments/Updates
        7.10.6 Sandoz Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Quetiapine Fumarate Sustained Release Tablets Industry Chain
    8.2 Quetiapine Fumarate Sustained Release Tablets Upstream Analysis
    8.3 Quetiapine Fumarate Sustained Release Tablets Midstream Analysis
    8.4 Quetiapine Fumarate Sustained Release Tablets Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Quetiapine Fumarate Sustained Release Tablets Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Quetiapine Fumarate Sustained Release Tablets Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Quetiapine Fumarate Sustained Release Tablets Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Quetiapine Fumarate Sustained Release Tablets Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Quetiapine Fumarate Sustained Release Tablets Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Quetiapine Fumarate Sustained Release Tablets Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Quetiapine Fumarate Sustained Release Tablets Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Quetiapine Fumarate Sustained Release Tablets Players in 2023
 Table 12. World Quetiapine Fumarate Sustained Release Tablets Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Quetiapine Fumarate Sustained Release Tablets Company Evaluation Quadrant
 Table 14. Head Office of Key Quetiapine Fumarate Sustained Release Tablets Players
 Table 15. Quetiapine Fumarate Sustained Release Tablets Market: Company Product Type Footprint
 Table 16. Quetiapine Fumarate Sustained Release Tablets Market: Company Product Application Footprint
 Table 17. Quetiapine Fumarate Sustained Release Tablets Mergers & Acquisitions Activity
 Table 18. United States VS China Quetiapine Fumarate Sustained Release Tablets Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Quetiapine Fumarate Sustained Release Tablets Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Quetiapine Fumarate Sustained Release Tablets Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue Market Share (2019-2024)
 Table 23. China Based Quetiapine Fumarate Sustained Release Tablets Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Quetiapine Fumarate Sustained Release Tablets Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Quetiapine Fumarate Sustained Release Tablets Revenue Market Share (2019-2024)
 Table 29. World Quetiapine Fumarate Sustained Release Tablets Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Quetiapine Fumarate Sustained Release Tablets Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Quetiapine Fumarate Sustained Release Tablets Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2025-2030) & (USD Million)
 Table 35. Luye Pharma Limited Basic Information, Manufacturing Base and Competitors
 Table 36. Luye Pharma Limited Major Business
 Table 37. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 38. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Luye Pharma Limited Recent Developments/Updates
 Table 40. Luye Pharma Limited Competitive Strengths & Weaknesses
 Table 41. PHARMATHEN INVESTMENTS GROUP LIMITED Basic Information, Manufacturing Base and Competitors
 Table 42. PHARMATHEN INVESTMENTS GROUP LIMITED Major Business
 Table 43. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 44. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. PHARMATHEN INVESTMENTS GROUP LIMITED Recent Developments/Updates
 Table 46. PHARMATHEN INVESTMENTS GROUP LIMITED Competitive Strengths & Weaknesses
 Table 47. Seroquel Basic Information, Manufacturing Base and Competitors
 Table 48. Seroquel Major Business
 Table 49. Seroquel Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 50. Seroquel Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Seroquel Recent Developments/Updates
 Table 52. Seroquel Competitive Strengths & Weaknesses
 Table 53. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
 Table 54. Teva Pharmaceutical Industries Major Business
 Table 55. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 56. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 58. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
 Table 59. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
 Table 60. Dr. Reddy's Laboratories Major Business
 Table 61. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 62. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 64. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
 Table 65. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
 Table 66. Sun Pharmaceutical Industries Major Business
 Table 67. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 68. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Sun Pharmaceutical Industries Recent Developments/Updates
 Table 70. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
 Table 71. Mylan N.V. Basic Information, Manufacturing Base and Competitors
 Table 72. Mylan N.V. Major Business
 Table 73. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 74. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Mylan N.V. Recent Developments/Updates
 Table 76. Mylan N.V. Competitive Strengths & Weaknesses
 Table 77. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 78. Torrent Pharmaceuticals Major Business
 Table 79. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 80. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Torrent Pharmaceuticals Recent Developments/Updates
 Table 82. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
 Table 83. Lupin Limited Basic Information, Manufacturing Base and Competitors
 Table 84. Lupin Limited Major Business
 Table 85. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 86. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Lupin Limited Recent Developments/Updates
 Table 88. Lupin Limited Competitive Strengths & Weaknesses
 Table 89. Sandoz Basic Information, Manufacturing Base and Competitors
 Table 90. Sandoz Major Business
 Table 91. Sandoz Quetiapine Fumarate Sustained Release Tablets Product and Services
 Table 92. Sandoz Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Sandoz Recent Developments/Updates
 Table 94. Sandoz Competitive Strengths & Weaknesses
 Table 95. Global Key Players of Quetiapine Fumarate Sustained Release Tablets Upstream (Raw Materials)
 Table 96. Global Quetiapine Fumarate Sustained Release Tablets Typical Customers


List of Figures
 Figure 1. Quetiapine Fumarate Sustained Release Tablets Picture
 Figure 2. World Quetiapine Fumarate Sustained Release Tablets Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Quetiapine Fumarate Sustained Release Tablets Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Quetiapine Fumarate Sustained Release Tablets Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Quetiapine Fumarate Sustained Release Tablets Revenue (2019-2030) & (USD Million)
 Figure 13. Quetiapine Fumarate Sustained Release Tablets Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Quetiapine Fumarate Sustained Release Tablets Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Quetiapine Fumarate Sustained Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Quetiapine Fumarate Sustained Release Tablets by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Quetiapine Fumarate Sustained Release Tablets Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Quetiapine Fumarate Sustained Release Tablets Markets in 2023
 Figure 27. United States VS China: Quetiapine Fumarate Sustained Release Tablets Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Quetiapine Fumarate Sustained Release Tablets Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Quetiapine Fumarate Sustained Release Tablets Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type in 2023
 Figure 31. 50mg
 Figure 32. 200mg
 Figure 33. 300mg
 Figure 34. 400mg
 Figure 35. World Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2019-2030)
 Figure 36. World Quetiapine Fumarate Sustained Release Tablets Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 37. World Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application in 2023
 Figure 38. Hospital
 Figure 39. Clinic
 Figure 40. Others
 Figure 41. World Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2019-2030)
 Figure 42. Quetiapine Fumarate Sustained Release Tablets Industrial Chain
 Figure 43. Methodology
 Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Luye Pharma Limited
PHARMATHEN INVESTMENTS GROUP LIMITED
Seroquel
Teva Pharmaceutical Industries
Dr. Reddy's Laboratories
Sun Pharmaceutical Industries
Mylan N.V.
Torrent Pharmaceuticals
Lupin Limited
Sandoz

Related Reports

Global Quetiapine Fumarate Sustained Release Tablets Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Quetiapine Fumarate Sustained Release Tablets Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 01 Aug 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Quetiapine Fumarate Sustained Release Tablets market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

Product Tags

Quetiapine Fumarate Sustained Release Tablets

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>